Adam C Palmer
@ac_palmer
Followers
795
Following
2K
Media
89
Statuses
759
Assistant Professor, Pharmacology and Computational Medicine at @UNC Measuring and modeling combination cancer therapy
Chapel Hill, NC
Joined May 2012
New paper by @AmyEPomeroy!. A model of intratumor and interpatient heterogeneity explains clinical trials of curative combination therapy for lymphoma. Out now in Blood Cancer Discovery @BCD_AACR. #mathonc #lymsm #BloodCancer.1/n.
7
8
30
RT @AACR: In the United States, the overall cancer death rate has been steadily declining since the 1990s, with the reductions between 1991….
0
2
0
RT @oncology_bg: Our new editorial just published in @BMJOncology led by @lateuwen where we discuss the use of inferior control arm in canc….
0
17
0
RT @JCO_ASCO: Remission Assessment by Circulating Tumor DNA in Large B-Cell Lymphoma. Co-authored by @AshAlizadeh, @RoschewskiMD, @DrJasonW….
ascopubs.org
PurposeLarge B-cell lymphomas (LBCL) are curable, but patients with residual disease after therapy invariably experience progression. Ultrasensitive methods to detect circulating tumor DNA (ctDNA) as...
0
11
0
RT @dgermain21: Here are some rambling thoughts of mine on this topic. I'm critical of studies that open with a control arm known to be in….
0
3
0
RT @ara_anderson: Abstract submission is now open for #MathOnco25! So please go ahead and submit asap to have a chance of getting one of ou….
0
3
0
RT @GreenLymphoLab: Save-the-date: AACR/ICML Advances In Malignant Lymphoma, June 24-27, 2026, Philadelphia. Featuring interactive sessions….
0
3
0
RT @VincentRK: What I have been worried about. We now spend more on health care than groceries or housing. And it’s not going to slow do….
0
7
0
RT @zakkohane: Atul Butte in memoriam @UCSF @StanfordMed @Harvard @BostonChildrens @BrownUniversity.
ucsf.edu
Atul Butte, who championed the use of big data in science and health care and inspired a generation of trainees at UC San Francisco and beyond to pursue the fields he pioneered — translational and...
0
23
0
RT @Dr_Daniel_Molin: The big debate 3: Smith vs Nowakowski: Is Pola-R-CHP the new standard for all DLBCL? No.
0
6
0
RT @FasaAgbedia: Pola-R-CHP the new SOC for ALL DLBCL?. @SoniSmithMD YES vs. @GregNowakowski NO. Pola-R-CHP, RCHOP.Some need Pola-R-CHP.Som….
0
3
0
Two great resources on the latest in lymphoma:. 1) MD Academy has free recordings of 2025 CLL+Lymphoma meeting. 2) Blood Cancer Discovery has a free collection of lymphoma articles, including a review on ctDNA applications. #lymsm.
academy.md-education.com
We are excited to share the video course from the 4th Annual CLL-Lymphoma US Focus Meeting 2025, held at the Marina del Rey Marriott Hotel, Santa Monica, CA, on May 2-3, 2025
4
0
2
RT @StephenVLiu: This is a major story from #ASCO25. Randomized phase 3 trial of time of day of immunotherapy infusion. Randomized to infus….
0
490
0
Clear and compelling interview with @baym on the harm of cutting funding to antibiotic research:. This affects so much of modern medicine; many cancer treatments, including regimens with curative intent, are only safe because of effective antibiotics.
wbur.org
Microbiologist Michael Baym studies antibiotic resistance at Harvard Medical School. He lost millions in federal funding this week.
0
15
24
RT @baym: Yesterday, the NIH R35 “Outstanding Investigator” grant to fund scientists in my lab studying antibiotic resistance was terminate….
0
221
0
RT @IBozic_: Thank you @ac_palmer for speaking in the MCMC seminar! The seminar recording is available here:
0
3
0
RT @IBozic_: Excited to announce the second Mathematical and Computational Modeling of Cancer (MCMC) Seminar speaker, Adam Palmer from Univ….
0
5
0
Entertaining interview with Louis Staudt about his work on molecular classification of cancers, and combination therapy. I liked his quote in support of ideas that "amuse your fellow biologists" - which might be his way of saying not everyone will like the idea at first
Congratulations to Dr. Louis Staudt, winner of the AACR Award for Outstanding Achievement in Blood Cancer Research. Attend Dr. Staudt's award lecture and read about his career path and scientific achievements in a Q&A article, online now #AACR25.
0
0
4
RT @CancerGrand: 🚨New in @Nature. Mutographs identified mutational signatures caused by the bacterial genotoxin colibactin are enriched in….
0
9
0
RT @BCD_AACR: A Model of Intratumor and Interpatient Heterogeneity Explains Clinical Trials of Curative Combination Therapy for Lymphoma: h….
0
1
0
RT @BCD_AACR: Beyond Trial and Error: A Mathematical Model Wrangles DLBCL Heterogeneity Toward Optimizing Combination Therapy https://t.co/….
0
3
0